These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31145811)

  • 1. Prioritization of Cochrane Systematic Reviews.
    Presley C; Rundle CW; Kolodziejczyk T; Andrews S; Shumaker P; Anand P; Lee K; Dellavalle RP; Boyle RJ
    Br J Dermatol; 2019 Dec; 181(6):1303-1304. PubMed ID: 31145811
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evidence-based medicine and the Cochrane Skin Group].
    Diepgen TL; Williams HC
    Hautarzt; 2005 Mar; 56(3):251-6. PubMed ID: 15717174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single screening or double screening for study selection in systematic reviews?
    Mahtani KR; Heneghan C; Aronson J
    BMJ Evid Based Med; 2020 Aug; 25(4):149-150. PubMed ID: 31722997
    [No Abstract]   [Full Text] [Related]  

  • 4. [Why guidelines?].
    Orfanos CE
    J Dtsch Dermatol Ges; 2014 Apr; 12(4):279-80. PubMed ID: 24698587
    [No Abstract]   [Full Text] [Related]  

  • 5. The Cochrane Skin Group: promoting the best evidence.
    Collier A; Johnson KR; Delamere F; Leonard T; Dellavalle RP; Williams H
    J Cutan Med Surg; 2005 Dec; 9(6):324-31. PubMed ID: 16699901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of quality of life in dermatology].
    Augustin M; Amon U; Braathen L; Bullinger M; Gieler U; Klein GF; Schultz-Amlung W
    J Dtsch Dermatol Ges; 2004 Sep; 2(9):802-6. PubMed ID: 16279226
    [No Abstract]   [Full Text] [Related]  

  • 7. Highlights of the updated Dutch evidence- and consensus-based guideline on psoriasis 2017.
    van der Kraaij GE; Balak DMW; Busard CI; van Cranenburgh OD; Chung Y; Driessen RJB; de Groot M; de Jong EMGJ; Kemperman PMJH; de Kort WJA; Karsch SA; Lamberts A; Lecluse LLA; van Lümig PPM; Menting SP; Prens EP; van den Reek JMPA; Seyger MMB; Thio HB; Veldkamp WR; Wakkee M; Nast A; Jacobs A; Rosumeck S; Spuls Chair PI
    Br J Dermatol; 2019 Jan; 180(1):31-42. PubMed ID: 30604536
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of absolute risk measurements in observational dermatology studies: important information for decision-making is frequently absent.
    Tjahjono LA; Cline A; Huang WW; Feldman SR
    Br J Dermatol; 2019 Mar; 180(3):678-679. PubMed ID: 30328103
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cryotherapy in dermatology].
    Hundeiker M; Sebastian G; Bassukas D; Ernst K
    J Dtsch Dermatol Ges; 2003 Apr; 1(4):322-7. PubMed ID: 16285489
    [No Abstract]   [Full Text] [Related]  

  • 10. Teledermatology: A Review and Update.
    Lee JJ; English JC
    Am J Clin Dermatol; 2018 Apr; 19(2):253-260. PubMed ID: 28871562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosomatic dermatology (psychodermatology).
    Harth W
    J Dtsch Dermatol Ges; 2008 Jan; 6(1):67-76. PubMed ID: 18021249
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of and perspectives on guidelines: what is important?
    Spuls PI; Nast A
    J Invest Dermatol; 2010 Oct; 130(10):2348-9. PubMed ID: 20842139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current guidelines in dermatology : A selection of clinically relevant recommendations].
    Nast A; Rosumeck S; Erdmann R; Dressler C; Werner RN
    Hautarzt; 2016 May; 67(5):391-6. PubMed ID: 27052528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.
    Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Akl EA; Brennan SE; Chou R; Glanville J; Grimshaw JM; Hróbjartsson A; Lalu MM; Li T; Loder EW; Mayo-Wilson E; McDonald S; McGuinness LA; Stewart LA; Thomas J; Tricco AC; Welch VA; Whiting P; Moher D
    PLoS Med; 2021 Mar; 18(3):e1003583. PubMed ID: 33780438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Austrian and European initiatives in the field of rare diseases perspectives for a "marginal group" of many millions of patients].
    Laimer M; Prodinger C; Ahlgrimm-Siess V; Hintner H; Bauer JW
    J Dtsch Dermatol Ges; 2015 Mar; 13(3):261-4. PubMed ID: 25721645
    [No Abstract]   [Full Text] [Related]  

  • 16. Usefulness of Cochrane Skin Group reviews for clinical practice.
    Davila-Seijo P; Batalla A; Garcia-Doval I
    Actas Dermosifiliogr; 2013 Oct; 104(8):679-84. PubMed ID: 23954044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Cochrane Skin Group. Preparing, maintaining, and disseminating systematic reviews of clinical interventions in dermatology.
    Williams H; Adetugbo K; Po AL; Naldi L; Diepgen T; Murrell D
    Arch Dermatol; 1998 Dec; 134(12):1620-6. PubMed ID: 9875203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interdisciplinary guidelines of the German Society of Coloproctology and the German Society of Dermatology. Anal skin tags.
    Brühl W; ;
    J Dtsch Dermatol Ges; 2006 Oct; 4(10):892-3. PubMed ID: 17010181
    [No Abstract]   [Full Text] [Related]  

  • 19. Guiding principles for prioritization of limited in-person dermatology appointments during the COVID-19 pandemic.
    Stoff BK; Blalock TW; Swerlick RA; MacKelfresh JB; Lawley LP; Chen SC
    J Am Acad Dermatol; 2020 Oct; 83(4):1228-1230. PubMed ID: 32682028
    [No Abstract]   [Full Text] [Related]  

  • 20. The Need for a National Strategy on Artificial Intelligence in Canadian Dermatology.
    Lewinson RT; Vallerand IA
    J Cutan Med Surg; 2020; 24(4):428-429. PubMed ID: 32363930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.